NASDAQ:ZSPH

ZS Pharma (ZSPH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ZSPH stock logo

About ZS Pharma Stock (NASDAQ:ZSPH)

ZS Pharma, Inc. is a biopharmaceutical company focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. The Company's zirconium silicate technology allows it to create selective ion traps that can reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. The Company has completed Phase III development of its product candidate, sodium zirconium cyclosilicate (ZS-9), for the treatment of hyperkalemia, a life-threatening condition in which elevated levels of potassium increase the risk of muscle dysfunction, including cardiac arrhythmias and sudden cardiac death. The Company has completed three clinical studies with ZS-9 for patients with hyperkalemia, including patients with chronic kidney disease (CKD), heart failure (HF), diabetes and those on renin-angiotensin aldosterone system (RAAS) inhibitor therapy.

ZSPH Stock News Headlines

Zscaler: This Is A Dip Well Worth Buying
Zscaler, Inc. (ZS)
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Zscaler Stock (NASDAQ:ZS), Quotes and News Summary
Zscaler, Inc. Common Stock (ZS)
Zscaler Inc.
Zscaler Inc ZS Stock Quote
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Guru Fundamental Report for ZS
Zscaler (NASDAQ: ZS)
Zs Pharma I (ZSPH)
See More Headlines
Receive ZSPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZS Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSPH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

ZSPH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ZS Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ZS Pharma investors own include (RLYP) (RLYP), Jazz Pharmaceuticals (JAZZ), Gilead Sciences (GILD), Pfizer (PFE), Allakos (ALLK), Boeing (BA), Alibaba Group (BABA), Bausch Health Companies (BHC), First Solar (FSLR).

This page (NASDAQ:ZSPH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners